We report the experiences of 5 patients taking bedaquiline with delamanid in combination: 1 patient was cured; 3 culture converted, with 2 continuing and 1 changing therapy; and 1 died from respiratory insufficiency. For 2 patients, QT-interval prolongation but no arrhythmias occurred. Use of this therapy is justified for patients with limited options.</p
BACKGROUND Patients with highly drug-resistant forms of tuberculosis have limited treatment options ...
Introduction: Few innovative anti-microbial products have been brought to market in recent years to ...
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant...
We report the experiences of 5 patients taking bedaquiline with delamanid in combination: 1 patient ...
The new drugs delamanid and bedaquiline are increasingly being used to treat multidrug-resistant (MD...
The new drugs delamanid and bedaquiline are increasingly being used to treat multidrug-resistant (MD...
There are limited data on combining delamanid and bedaquiline in drug-resistant tuberculosis (DR-TB)...
Bedaquiline and delamanid have been approved for treatment of multidrug-resistant (MDR) tuberculosis...
The World Health Organization (WHO) recommends countries introduce new anti-TB drugs in the treatmen...
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant...
BACKGROUND: Concomitant use of bedaquiline (Bdq) and delamanid (Dlm) for multi-drug/rifampicin resis...
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant...
BackgroundIn 2012, the Food and Drug Administration approved use of bedaquiline fumarate as part of ...
BACKGROUND Patients with highly drug-resistant forms of tuberculosis have limited treatment options ...
Introduction: Few innovative anti-microbial products have been brought to market in recent years to ...
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant...
We report the experiences of 5 patients taking bedaquiline with delamanid in combination: 1 patient ...
The new drugs delamanid and bedaquiline are increasingly being used to treat multidrug-resistant (MD...
The new drugs delamanid and bedaquiline are increasingly being used to treat multidrug-resistant (MD...
There are limited data on combining delamanid and bedaquiline in drug-resistant tuberculosis (DR-TB)...
Bedaquiline and delamanid have been approved for treatment of multidrug-resistant (MDR) tuberculosis...
The World Health Organization (WHO) recommends countries introduce new anti-TB drugs in the treatmen...
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant...
BACKGROUND: Concomitant use of bedaquiline (Bdq) and delamanid (Dlm) for multi-drug/rifampicin resis...
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant...
BackgroundIn 2012, the Food and Drug Administration approved use of bedaquiline fumarate as part of ...
BACKGROUND Patients with highly drug-resistant forms of tuberculosis have limited treatment options ...
Introduction: Few innovative anti-microbial products have been brought to market in recent years to ...
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant...